Joya, Maribel L.

HRN: 28-93-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2026
CEFTRIAXONE 1G (VIAL)
05/02/2026
05/09/2026
IV
1g
Q12
Avulsed Wound Right Knee
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: